{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "A",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to PD, which is the loss of dopaminergic neurons."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assays were used to determine the kinase activities of the LRRK2 variants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the functional impact of variants in kinase domains, which is relevant to the pathogenesis of PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of in vitro kinase assays, which are a well-established method for assessing kinase activity. The assays included both autokinase and substrate phosphorylation activities, providing a comprehensive评估 of kinase function."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "p.G2385R showed higher kinase activity than wild type, consistent with a toxic gain of function mechanism.",
          "judgment": "Yes",
          "reasoning": "The functional assay results support the pathogenicity of the p.G2385R variant by demonstrating increased kinase activity, which is consistent with the known mechanism of disease.",
          "next_step_or_outcome": "PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The p.G2385R variant in LRRK2 was associated with increased kinase activity in vitro, consistent with a toxic gain of function mechanism implicated in PD. The functional evidence supports a very strong pathogenic classification for this variant."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "1398"
        },
        "variant_string_id": "LRRK2 R1398H"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to PD, which is the loss of dopaminergic neurons."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assays were used to determine the kinase activities of the LRRK2 variants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the functional impact of variants in kinase domains, which is relevant to the pathogenesis of PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of in vitro kinase assays, which are a well-established method for assessing kinase activity. The assays included both autokinase and substrate phosphorylation activities, providing a comprehensive评估 of kinase function."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "p.R1398H had significantly lower kinase activity than wild type, suggesting a protective effect.",
          "judgment": "Yes",
          "reasoning": "The functional assay results support a protective effect for the p.R1398H variant by demonstrating decreased kinase activity, which is consistent with a reduced risk of PD.",
          "next_step_or_outcome": "BS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_very_strong"
      },
      "overall_conclusion": "The p.R1398H variant in LRRK2 was associated with decreased kinase activity in vitro, suggesting a protective effect against PD. The functional evidence supports a very strong benign classification for this variant."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "1628"
        },
        "variant_string_id": "LRRK2 R1628P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to PD, which is the loss of dopaminergic neurons."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro kinase assays were used to determine the kinase activities of the LRRK2 variants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the functional impact of variants in kinase domains, which is relevant to the pathogenesis of PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of in vitro kinase assays, which are a well-established method for assessing kinase activity. The assays included both autokinase and substrate phosphorylation activities, providing a comprehensive评估 of kinase function."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "p.R1628P showed higher kinase activity than wild type, consistent with a toxic gain of function mechanism.",
          "judgment": "Yes",
          "reasoning": "The functional assay results support the pathogenicity of the p.R1628P variant by demonstrating increased kinase activity, which is consistent with the known mechanism of disease.",
          "next_step_or_outcome": "PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The p.R1628P variant in LRRK2 was associated with increased kinase activity in vitro, consistent with a toxic gain of function mechanism implicated in PD. The functional evidence supports a very strong pathogenic classification for this variant."
    }
  ]
}